House Passes Watered-Down Zika Aid Bill

The legislation allocates only $622 million to the effort to help the country respond to the impending spread of the mosquito-borne disease.

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, US DEPARTMENT OF AGRICULTUREThe White House and Democrats in the US Congress railed against a defanged version of a Zika funding bill passed Wednesday (May 18) by the US House. The bill, which passed on a 241-184 vote along party lines, allocates only $622 million to help officials that will be faced with the spread of the Zika virus to the U.S. as temperatures start to warm and mosquitoes breed. The Obama administration had asked for $1.9 billion to fight Zika—which is expected to reach as far north as New Jersey and Ohio and as far west as California this summer—and the Senate has approved $1.1 billion in spending.

The White House has threatened to veto the scaled-back bill, calling it “woefully inadequate.”

The House bill would provide funding through the end of September to state and local health departments, Zika vaccine research, and mosquito control. The heftier Senate bill would aid the fight against Zika through September 2017. The main sticking points between the Congressional bodies are where the money would come from, with House Republicans insisting on budgetary cuts elsewhere to offset the Zika funds.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies